Joint Corp Stock Price, News & Analysis

The Joint Corp. (NASDAQ: JYNT), the largest franchisor of chiropractic care in the US, has been recognized as one of the Top 50 Franchises by SUCCESS Magazine in its May/June 2024 money issue. The Joint is featured in the health and wellness category, with SUCCESS highlighting the brand's support, recognition, and economies of scale.

Peter D. Holt, President and CEO of The Joint Corp., expressed gratitude for the recognition, emphasizing the benefits of franchising. The Joint Chiropractic is renowned for its convenient retail setting and concierge-style services, offering patients no-appointment, no-insurance hassle chiropractic care with affordable prices and flexible hours, including evenings and weekends.

The Joint Corp. (NASDAQ: JYNT), the largest provider of chiropractic care in the US through The Joint Chiropractic® network, has announced its participation in the 7th Annual B. Riley Securities Consumer & TMT Conference. The event is scheduled for Thursday, September 12, 2024, at the Sofitel New York.

Key details:

• President and CEO Peter D. Holt and CFO Jake Singleton will represent the company
• They will conduct one-on-one meetings throughout the day
• Interested parties can contact their B. Riley Securities representative for more information

This participation indicates The Joint Corp.'s commitment to investor relations and its potential interest in discussing business strategies, market trends, and growth opportunities in the chiropractic care sector.

The Joint Corp. (NASDAQ: JYNT), the largest provider of chiropractic care in the US, has opened its first clinic in San Francisco. Located at 1549-A Sloat Blvd. in Lakeshore Plaza, it's the second location for franchisee Jacki Walker. This expansion is part of The Joint's strategy to grow coast to coast and provide accessible chiropractic care in diverse communities.

The Joint Chiropractic offers convenient, affordable care without appointments or insurance hassles. Walker, who also owns franchises of another health and wellness concept, brought The Joint to San Francisco because she felt the area was underserved in terms of chiropractic care. The new clinic aims to provide easy access to routine care without appointments or insurance requirements.

The Joint Corp. (NASDAQ: JYNT) reported Q2 2024 financial results with a 3% revenue growth to $30.3 million compared to Q2 2023. The company experienced a net loss of $3.6 million due to litigation expenses, loss on disposition or impairment, and costs from an in-person franchise conference. Adjusted EBITDA decreased to $2.1 million from $3.2 million in Q2 2023. System-wide sales grew 8% to $129.6 million, and system-wide comp sales increased 2%.

Key metrics:

• Total clinic count rose to 960.
• Seven franchise licenses sold, down from 21 in Q2 2023.

For the first half of 2024, revenue was $60 million, up from $57.6 million in H1 2023. Net loss reached $2.6 million, compared to a net income of $2 million in H1 2023. The company reiterated its full-year guidance with system-wide sales expected between $530-$545 million and new franchised clinic openings between 60-75.

The Joint Corp. (NASDAQ: JYNT), the largest provider of chiropractic care in the US, has announced its upcoming second quarter 2024 financial results report. The company will release its results on Thursday, August 8, 2024, after market close. Following the release, President and CEO Peter D. Holt and CFO Jake Singleton will host a conference call at 5:00 p.m. EDT to discuss the results.

Shareholders and interested parties can join the live broadcast by dialing 1-(833) 630-0823 or (412) 317-1831 and asking to join 'The Joint' call. A live webcast with accompanying slides will be available in the IR events section of the company's website. An audio archive will be accessible for one week after the call.

The Joint Corp. has engaged Capstone Partners to accelerate its refranchising efforts. The agreement aims to select effective franchisees to support system growth and increase asset value. Capstone will help identify qualified franchisees for large transactions, enhancing value for stakeholders. The Joint Corp. is a leader in retail chiropractic, offering strong unit economics and growth opportunities.

The Joint Corp. (NASDAQ: JYNT) will participate in two upcoming investor conferences held by B. Riley and Oppenheimer. President and CEO Peter Holt, along with CFO Jake Singleton, will represent the company. Interested investors can access a webcast of the Oppenheimer presentation on the company's investor relations website.

The Joint Corp. reported its financial results for the first quarter of 2024, showing a 5% revenue growth, 9% system-wide sales increase, and 3% system-wide comp sales rise compared to Q1 2023. The company also tripled franchise license sales, opened 23 clinics, and closed four, increasing the clinic count to 954. Adjusted EBITDA was $3.5 million, net income was $947,000, and operating income improved from a loss to $1.1 million. The company aims to be the 'Champions of Chiropractic' and highlighted their progress in revenue growth and refranchising efforts.